Demo
Close Language Tab
Locate us
Languages
S
Sigachi Industries Ltd Pharmaceuticals
₹ 38.18 -0.89 (-2.28%)
  • NSE
  • BSE

Overview

  • BSE Code 543389
  • NSE Symbol SIGACHI
  • ISIN Demat INE0D0K01022
  • Book Value (₹) 14.65
  • Face Value (₹) 1.00
  • Market Cap (₹ Cr.) 1,504.39
  • P/E (TTM) 31.50
  • EPS (TTM) 1.25
  • Div Yield (%) 0.00

Performance

Today’s Low 37.97
Today’s High 39.45

38.18
52W Low 34.00
52W High 69.89

38.18
Open 39.45
Prev. Close 39.07
Volume 26,45,177.00

Corporate Actions

Sigachi Industries Limited - Press Release
Apr 28, 2025

Sigachi Industries Limited has informed the Exchange regarding a press release dated April 28, 2025, titled "Signing of a Memorandum of Understanding (MoU) between Sigachi Industries Limited and Respilon Group sro".

Sigachi Industries Limited - Disclosure under SEBI Takeover Regulations
Apr 28, 2025

Amit Raj Sinha has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

About Sigachi Industries Ltd

Sigachi Industries Limited was initially formed as 'Sigachi Chloro-Chemicals Private Limited' on 11 January, 1989. To diversify the business activities, name of the Company was changed to 'Sigachi Industries Private Limited' on 29 March, 2012. Subsequently, Company was converted from a Private Limited to a Public Limited and consequently, name was changed to 'Sigachi Industries Limited' effective on 19 December, 2019.

the Company is is one of the major producer and distributor of Micro Crystalline Cellulose Powder(MCCP). the Company currently offers 59 distinct grades of MCC through its two state-of-the-art manufacturing facilities in Hyderabad and Gujarat, with a total installed capacity of 11,880 MTPY. Apart from these, it is an industry leader in the field of Pharma Excipients, Nutra and food ingredients.

the Company has incorporated a wholly owned subsidiary ,namely Sigachi US,Inc on 20 January 2017.the Company had invested USD 20000 towards share capital.

During the FY2020,the Company has allotted 4609500 equity shares of Rs 10 each as bonus shares to the existing shareholders in the ratio of 3:2.

During the month of November 2021,the Company came out with an Rs 125.43-crore public issue comprises 7695000 fresh issue of shares and these IPO shares were allotted at a price of Rs 163 per share,including premium of Rs 153 per share.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India Ltd(NSE) on 15 November 2021.

the Company expanded its business into OTC, nutraceutical and Food & Nutrition markets in 2022-23. the Company incorporated a wholly owned subsidiary in Dubai, UAE by the name of 'Sigachi MENA FZCO' on March 6, 2023.

In 2024, Company acquired 80% equity stake in Trimax Bio Sciences Pvt Ltd and became a leading player in the API division. The

Company's subsidiary Company Sigachi MENA FZCO has announced formation of a Joint Venture (JV) 'Sigachi Arabia' with Saudi National Projects Investment Limited (SNP).

Founded: 1989
Chairman: Rabindra Prasad Sinha
Managing Director: Amit Raj Sinha
Address: 229/1 & 90 4th Floor Kalyan's, Tulsiram Chambers Madinaguda, Hyderabad, Telangana, 500049,